Clindamycin (ANTIROBE) for Bacterial Vaginosis
|113,851 Patients Studied||139 Studies (View)|
Definition: Clindamycin rINN is a lincosamide antibiotic. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria. It is a common topical treatment for acne and can be useful against some methicillin-resistant Staphylococcus aureus (MRSA) infections. The most severe common adverse effect of clindamycin is Clostridium difficile-associated diarrhea (the most frequent cause of pseudomembranous colitis). Bacterial vaginosis (BV) or less commonly vaginal bacteriosis is the most common cause of vaginal infection. It is not considered to be a sexually transmitted infection by the CDC. Research is currently ongoing regarding the transmission mechanisms of BV, but it is more common in women who are sexually active. BV is caused by an imbalance of naturally occurring bacterial flora and is often confused with yeast infection, or infection with Trichomonas vaginalis, which are not caused by bacteria. (SOURCE: Wikipedia)
Where does Clindamycin (ANTIROBE) rank compared to other Bacterial Vaginosis treatments?
Health experts published 139 studies on Clindamycin and Bacterial Vaginosis making Clindamycin the #1 most researched treatment. In research involving Bacterial Vaginosis, experts have concluded that Clindamycin is effective in 16 studies and safe in 14 studies.
Health experts published 277 studies on Metronidazole and Bacterial Vaginosis making Metronidazole the #3 most researched treatment. In research involving Bacterial Vaginosis, experts have concluded that Metronidazole is effective in 32 studies and safe in 14 studies.
What peer treatments do patients prefer?
What does the FDA say about side effects?
Most Researched Conditions
What other conditions have been studied?
Most Discussed Conditions
What treatments have patients discontinued using?